Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment

被引:16
|
作者
Nyberg, Eric [1 ]
Honce, Justin [1 ]
Kleinschmidt-DeMasters, Bette K. [2 ,3 ]
Shukri, Brian [1 ]
Kreidler, Sarah [4 ]
Nagae, Lidia [1 ]
机构
[1] Univ Colorado Hosp, Dept Radiol, 12605 E 16th Ave, Aurora, CO 80045 USA
[2] Univ Colorado Hosp, Dept Pathol, Aurora, CO USA
[3] Univ Colorado Hosp, Dept Neurol & Neurosurg, Aurora, CO USA
[4] Neptune & Co Inc, Los Alamos, NM USA
关键词
Arterial spin labeling; MR perfusion; glioblastoma; radiation necrosis; pseudoprogression;
D O I
10.1177/1971400916665375
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background: Standard of care for high-grade gliomas (HGGs) includes surgical debulking and adjuvant chemotherapy and radiation. Patients under treatment require frequent clinical and imaging monitoring for therapy modulation. Differentiating tumor progression from treatment-related changes can be challenging on conventional MRI, resulting in delayed recognition of tumor progression. Arterial spin labeling (ASL) may be more sensitive for tumor progression. Materials and methods: ASL and associated conventional MR images obtained in patients previously treated for HGGs and before biopsy or re-resection were reviewed by three neuroradiologists who were blinded to the histopathologic results. Regions of interest (ROIs) of greatest perfusion were chosen by consensus, and mirror-image contralateral ROIs were also placed. Sensitivity of ASL for tumor progression was compared with those of contrast-enhanced T1-weighted (T1W-CE) and fluid-attenuated inversion recovery (FLAIR) images using McNemar's test. We tested for an association between cerebral blood flow (CBF) and apparent diffusion correlation (ADC) using a Hotelling-Lawley trace. Finally, we used a Pearson's analysis to test for a correlation between CBF and percentage of tumor within each resection. Results: Twenty-two patients were studied. ASL demonstrated hyperperfusion in all cases with mean CBF ratio 3.37 (+/-1.71). T1W-CE and FLAIR images were positive in 15 (p = 0.0233) and 16 (p = 0.0412) cases, respectively. There was no association between ADC and CBF (p = 0.687). There was a correlation between CBF and percentage of tumor (p = 0.048). Conclusion: ASL may be more sensitive than conventional MR sequences for the detection of tumor progression in patients treated for HGGs.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 50 条
  • [21] Survival implications of postoperative restricted diffusion in high-grade glioma and limitations of intraoperative MRI detection
    Aaronson, Daniel M.
    Laing, Brandon
    Singhal, Ishan
    Boerger, Timothy F.
    Beck, Ryan T.
    Mueller, Wade M.
    Krucoff, Max O.
    JOURNAL OF NEURO-ONCOLOGY, 2024, 170 (02) : 419 - 428
  • [22] Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma
    Zuniga, Richard M.
    Torcuator, Roy
    Jain, Rajan
    Anderson, John
    Doyle, Thomas
    Schultz, Lonni
    Mikkelsen, Tom
    JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (02) : 237 - 242
  • [23] Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma
    Richard M. Zuniga
    Roy Torcuator
    Rajan Jain
    John Anderson
    Thomas Doyle
    Lonni Schultz
    Tom Mikkelsen
    Journal of Neuro-Oncology, 2010, 99 : 237 - 242
  • [24] MRI assessment of treatment delivery for interstitial photodynamic therapy of high-grade glioma in a preclinical model
    Leroy, Henri-Arthur
    Vermandel, Maximilien
    Leroux, Bertrand
    Duhamel, Alain
    Lejeune, Jean-Paul
    Mordon, Serge
    Reyns, Nicolas
    LASERS IN SURGERY AND MEDICINE, 2018, 50 (05) : 460 - 468
  • [25] Utility of intravoxel incoherent motion magnetic resonance imaging and arterial spin labeling for recurrent glioma after bevacizumab treatment
    Miyoshi, Fuminori
    Shinohara, Yuki
    Kambe, Atsushi
    Kuya, Keita
    Murakami, Atsushi
    Kurosaki, Masamichi
    Ogawa, Toshihide
    ACTA RADIOLOGICA, 2018, 59 (11) : 1372 - 1379
  • [26] Diagnostic Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade Gliomas: A Prospective Study
    Nguyen, T. B.
    Zakhari, N.
    Velasco Sandoval, S.
    Guarnizo-Capera, A.
    Alexios Gulak, M.
    Woulfe, J.
    Jansen, G.
    Thornhill, R.
    Majtenyi, N.
    Cron, G. O.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2023, 44 (02) : 134 - 142
  • [27] Posttreatment DSC-MRI is Predictive of Early Treatment Failure in Children with Supratentorial High-Grade Glioma Treated with Erlotinib
    Lucas, John T., Jr.
    Knapp, Brendan J.
    Uh, Jinsoo
    Hua, Chia-Ho
    Merchant, Thomas E.
    Hwang, Scott N.
    Patay, Zoltan
    Broniscer, Alberto
    CLINICAL NEURORADIOLOGY, 2018, 28 (03) : 393 - 400
  • [28] New Subependymal Enhancement After Radiation Therapy in High-Grade Glioma: Utilizing Morphological Features and DSC Perfusion MRI in Differentiate Progression and Post-Radiation Changes
    Choi, Kyu Sung
    Hwang, Inpyeong
    Park, Chul Kee
    Park, Sung Hye
    Choi, Seung Hong
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2025, 61 (04) : 1751 - 1760
  • [29] Role of modeled high-grade glioma cell invasion and survival on the prediction of tumor progression after radiotherapy
    Hager, Wille
    Toma-Dasu, Iuliana
    Astaraki, Mehdi
    Lazzeroni, Marta
    PHYSICS IN MEDICINE AND BIOLOGY, 2025, 70 (06)
  • [30] Patterns of failure after multimodal treatments for high-grade glioma: effectiveness of MIB-1 labeling index
    Uehara, Kazuyuki
    Sasayama, Takashi
    Miyawaki, Daisuke
    Nishimura, Hideki
    Yoshida, Kenji
    Okamoto, Yoshiaki
    Mukumoto, Naritoshi
    Akasaka, Hiroaki
    Nishihara, Masamitsu
    Fujii, Osamu
    Soejima, Toshinori
    Sugimura, Kazuro
    Kohmura, Eiji
    Sasaki, Ryohei
    RADIATION ONCOLOGY, 2012, 7